XML 114 R38.htm IDEA: XBRL DOCUMENT
v3.25.1

SHAREHOLDERS' EQUITY (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2024
Stockholders' Equity Note [Abstract] |
Schedule of ordinary shares reserved for future issuance |
| As of December 31,
| 2024 |  | 2023
Ordinary shares | 50,773,337 |  | 48,923,903
Outstanding share options and RSUs | 3,164,395 |  | 4,294,853
Shares available for future grants under the 2021 plan | 8,941,243 |  | 7,847,149
Shares available for future grants under the 2024 Foundation plan | 15,000 |  | –
Shares subject to the employee share purchase plan | 1,156,437 |  | 1,233,812
Total | 64,050,412 |  | 62,299,717
Schedule of share option activity |
|  |  | Weighted- |  | Weighted |  |
|  |  | Average |  | Average |  | Aggregate
| Number of |  | Exercise |  | Remaining |  | Intrinsic
| Options |  | Price |  | Contractual life |  | Value
Outstanding— |  |  |  |  |  |  |
January 1, 2024 (*) | 3,079,252 | $ | 48.82 | 6.71 | $ | 435,699
Granted (*) | 32,802 | $ | 0 |  |  |  |
Exercised | (1,220,551) | $ | 23.99 |  |  |  |
Expired and forfeited | (123,273) | $ | 79.84 |  |  |  |
Outstanding — |  |  |  |  |  |  |
December 31, 2024 | 1,768,230 | $ | 62.90 | 6.04 | $ | 305,379
Exercisable— |  |  |  |  |  |  |
December 31, 2024(*) | 1,403,701 | $ | 53.66 | 5.72 | $ | 255,421
(*) Includes 73,074 performance-based options granted to the Company’s Co-CEOs in 2022, 74,108 in 2023, and 22,481 in 2024, as applicable.
Schedule of unvested restricted stock units |
| Number of Units |  | Weighted- Average Fair Value
Balance at January 1, 2024 | 1,215,601 | $ | 134.41
Granted (*) | 824,855 | $ | 216.30
Vested | (483,508) | $ | 142.35
Canceled | (160,783) | $ | 154.56
Balance at December 31, 2024 (*) | 1,396,165 | $ | 177.72
(*) Includes 22,928 performance-based awards granted to the Company’s Co-CEOs in 2023, and 48,129 performance-based awards to the Company’s Co-CEOs and several executives in 2024.
Schedule of share-based compensation expense |
|  | Year ended December 31,
|  | 2024 |  | 2023 |  | 2022
Cost of revenues | $ | 6,603 | $ | 6,307 | $ | 10,406
Research and development |  | 50,995 |  | 38,737 |  | 32,957
Sales and marketing |  | 33,865 |  | 25,395 |  | 33,457
General and administrative |  | 55,654 |  | 29,747 |  | 28,100
Share-based compensation, net of amounts capitalized | $ | 147,117 | $ | 100,186 | $ | 104,920
Capitalized share-based compensation costs |  | 1,144 |  | 1,997 |  | 2,282
Total share-based compensation | $ | 148,261 | $ | 102,183 | $ | 107,202

X
- Definition Schedule of aggregate number of common stock ordinary shares reserved for future issuance. + References No definition available. + Details
Name: | mndy_ScheduleOfCommonStockOrdinarySharesReservedForFutureIssuanceTableTextBlock
Namespace Prefix: | mndy_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the change in restricted stock units (RSUs). + References No definition available. + Details
Name: | us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration